Todd Girolamo, JD, MBA
Todd Girolamo joined Caladrius in 2011. He is a seasoned attorney specializing in health-related products and businesses. As a member of the senior management team, Mr. Girolamo is responsible for managing all legal aspects of the Company’s research and development pipeline, from preclinical research to multinational pivotal clinical trials, including academic and corporate collaborations. He is responsible for the Company’s SEC, Nasdaq, and clinical compliance; execution of the Company’s financing, M&A and licensing activities; the strategy, maintenance and prosecution of the Company’s extensive global patent estate; and the management of all litigation involving the Company and its subsidiaries. Mr. Girolamo serves on the Company’s executive management and business development committees.
Mr. Girolamo began his legal career as a corporate law associate at Cahill Gordon & Reindel and concluded his tenure in private practice at Reid & Priest where he gained expertise as a general commercial litigator practicing in the areas of intellectual property, securities law, employment law and bankruptcy. In addition to almost two decades of experience as both corporate counsel and private practitioner, Mr. Girolamo spent 12 years on Wall Street where he specialized in therapeutic healthcare equity securities at Oppenheimer & Co., CIBC World Markets, Leerink & Company and Summer Street Research Partners as a Series 24, 7 and 63 licensed principal. Subsequently he served as an analyst and portfolio manager at Lion’s Path Capital, managing a long-short portfolio of biopharma and med-tech equities.
Mr. Girolamo received a Bachelor of Arts from Harvard College, Juris Doctor from the University of Pennsylvania Law School and Master of Business Administration from Columbia Business School.